Literature DB >> 19490814

Allergic rhinitis and aspirin-exacerbated respiratory disease as predictors of the olfactory outcome after endoscopic sinus surgery.

Michael Katotomichelakis1, Maria Riga, Spyridon Davris, Gregorios Tripsianis, Maria Simopoulou, Nikolaos Nikolettos, Konstantinos Simopoulos, Vasilios Danielides.   

Abstract

BACKGROUND: Unlike the functional outcomes of endoscopic sinus surgery, which have been thoroughly studied, the effect of the surgery on olfactory performance and the relative predictive factors have not been adequately assessed by literature. Allergic rhinitis and aspirin-exacerbated respiratory disease (AERD) are examined as potential confounding factors of the olfactory outcome in patients with extensive nasal polyposis and rhinosinusitis treated with functional endoscopic sinus surgery (FESS).
METHODS: A population of 116 adults with severe nasal polyposis was subjected to FESS after failure of the appropriate medical treatment. The olfactory outcome was quantified by Sniffin' Sticks at the 1st, 3rd, and 6th postoperative month in relation to the concomitant presence of allergic rhinitis (n = 62) or AERD (n = 18).
RESULTS: Allergic patients seemed to perform worse than nonallergic patients at all time frames. However, when patients with similar olfactory acuity, age, and medical history are compared, allergic rhinitis does not seem to affect the postoperative improvement of the composite threshold-discrimination-identification scores. The same seems to apply for the likelihood of acquiring normosmia after surgery. On the contrary, AERD significantly limits the recovery of olfactory function at all follow-up examinations and patients with AERD are unlikely to become normosmic.
CONCLUSION: The olfactory recovery after FESS for nasal polyposis is significantly affected by the concomitant presence of AERD. Although allergy seems to have a general negative effect on olfactory acuity, it was not found to affect the extent of the olfactory improvement, when patients with comparable preoperative characteristics are addressed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490814     DOI: 10.2500/ajra.2009.23.3325

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  8 in total

Review 1.  Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.

Authors:  Mauricio López-Chacón; Joaquim Mullol; Laura Pujols
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 2.  Anosmia-A Clinical Review.

Authors:  Sanne Boesveldt; Elbrich M Postma; Duncan Boak; Antje Welge-Luessen; Veronika Schöpf; Joel D Mainland; Jeffrey Martens; John Ngai; Valerie B Duffy
Journal:  Chem Senses       Date:  2017-09-01       Impact factor: 3.160

Review 3.  Aspirin-exacerbated respiratory disease in China: a cohort investigation and literature review.

Authors:  Yunping Fan; Shaoyan Feng; Wentong Xia; Lijuan Qu; Xiaomin Li; Shulin Chen; Minhong Ding; Yinyan Lai; Jianbo Shi; Geng Xu; Huabin Li
Journal:  Am J Rhinol Allergy       Date:  2012 Jan-Feb       Impact factor: 2.467

Review 4.  Aspirin-sensitive asthma and upper airway diseases.

Authors:  Jinny E Chang; William Chin; Ronald Simon
Journal:  Am J Rhinol Allergy       Date:  2012 Jan-Feb       Impact factor: 2.467

5.  Immunomodulatory treatments for aspirin exacerbated respiratory disease.

Authors:  Rachel G Moebus; Joseph K Han
Journal:  Am J Rhinol Allergy       Date:  2012 Mar-Apr       Impact factor: 2.467

6.  Differences in men and women suffering from CRSwNP and AERD in quality of life.

Authors:  Tina J Bartosik; David T Liu; Nicholas J Campion; Sergio Villazala-Merino; Stefan Janik; Valerie Dahm; Christian A Mueller; Erich Vyskocil; Victoria Stanek; Tamara Quint; Christine Bangert; Julia Eckl-Dorna; Sven Schneider
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-15       Impact factor: 2.503

Review 7.  Samter's Triad: State of the Art.

Authors:  Sung-Dong Kim; Kyu-Sup Cho
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-04-13       Impact factor: 3.372

8.  Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease.

Authors:  Sven Schneider; Nicholas J Campion; Sergio Villazala-Merino; David Tianxiang Liu; Tina Bartosik; Lukas D Landegger; Navid Ahmadi; Christian A Mueller; Erich Vyskocil; Victoria Stanek; Tamara Quint; Christine Bangert; Julia Eckl-Dorna
Journal:  J Clin Med       Date:  2020-03-28       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.